Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia

被引:250
作者
Kaidi, Abderrahmane [1 ]
Qualtrough, David [1 ]
Williams, Ann C. [1 ]
Paraskeva, Christos [1 ]
机构
[1] Univ Bristol, Fac Med & Vet Sci, Dept Cellular & Mol Med, Canc Res UK,Colorectal Tumor Biol Res Grp, Bristol BS8 1TD, Avon, England
关键词
D O I
10.1158/0008-5472.CAN-06-0425
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclooxygenase (COX)-2, the inducible key enzyme for prostanoid biosynthesis, is overexpressed in most colorectal carcinomas and a subset of colorectal adenomas. Genetic, biochemical, and clinical evidence indicates an important role for COX-2 in colorectal tumorigenesis. Although COX-2 can be induced by aberrant growth factor signaling and oncogene activation during colorectal tumorigenesis, the role of micro-environmental factors such as hypoxia in COX-2 regulation remains to be elucidated. For the first time, we report that under hypoxic conditions COX-2 protein levels increase in colorectal adenoma and carcinoma cells. Rigorous analyses reveal that COX-2 up-regulation is transcriptional and is associated with hypoxia-inducible factor (HIF)-1 alpha. induction. Oligonucleotide pull-down and chromatin immunoprecipitation assays reveal that HIF-1 alpha binds a hypoxia-responsive element on the COX-2 promoter. COX-2 up-regulation during hypoxia is accompanied by increased levels of prostaglandin E-2 (PGE(2)), which promote tumor cell survival under hypoxic conditions. In addition, elevated levels of PGE(2) in hypoxic colorectal tumor cells enhance vascular endothelial growth factor expression and HIF-1 transcriptional activity by activating the mitogen-activated protein kinase pathway, showing a potential positive feedback loop that contributes to COX-2 up-regulation during hypoxia. This study identifies COX-2 as a direct target for HIF-1 in colorectal tumor cells. In addition, COX-2 up-regulation represents a pivotal cellular adaptive response to hypoxia with implication for colorectal tumor cell survival and angiogenesis. We propose that using modified COX-2-selective inhibitors, which are only activated under hypoxic conditions, could potentially be a novel more selective strategy for colorectal cancer prevention and treatment.
引用
收藏
页码:6683 / 6691
页数:9
相关论文
共 51 条
  • [1] Araki Y, 2003, CANCER RES, V63, P728
  • [2] An essential role for p300/CBP in the cellular response to hypoxia
    Arany, Z
    Huang, LE
    Eckner, R
    Bhattacharya, S
    Jiang, C
    Goldberg, MA
    Bunn, HF
    Livingston, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) : 12969 - 12973
  • [3] Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium
    Bonazzi, A
    Mastyugin, V
    Mieyal, PA
    Dunn, MW
    Laniado-Schwartzman, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) : 2837 - 2844
  • [4] COX-2: A molecular target for colorectal cancer prevention
    Brown, JR
    DuBois, RN
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2840 - 2855
  • [5] Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
    Carmeliet, P
    Dor, Y
    Herbert, JM
    Fukumura, D
    Brusselmans, K
    Dewerchin, M
    Neeman, M
    Bono, F
    Abramovitch, R
    Maxwell, P
    Koch, CJ
    Ratcliffe, P
    Moons, L
    Jain, RK
    Collen, D
    Keshet, E
    [J]. NATURE, 1998, 394 (6692) : 485 - 490
  • [6] Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression
    Chang, SH
    Liu, CH
    Conway, R
    Han, DK
    Nithipatikom, K
    Trifan, OC
    Lane, TF
    Hla, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) : 591 - 596
  • [7] Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence
    Chell, SD
    Witherden, AR
    Dobson, RR
    Moorghen, M
    Herman, AA
    Qualtrough, D
    Williams, AC
    Paraskeva, C
    [J]. CANCER RESEARCH, 2006, 66 (06) : 3106 - 3113
  • [8] A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammmatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate
    Crew, TE
    Elder, DJE
    Paraskeva, C
    [J]. CARCINOGENESIS, 2000, 21 (01) : 69 - 77
  • [9] Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1α in non-small cell lung cancer
    Csiki, I
    Yanagisawa, K
    Haruki, N
    Nadaf, S
    Morrow, JD
    Johnson, DH
    Carbone, DP
    [J]. CANCER RESEARCH, 2006, 66 (01) : 143 - 150
  • [10] UP-REGULATION OF CYCLOOXYGENASE-2 GENE-EXPRESSION IN HUMAN COLORECTAL ADENOMAS AND ADENOCARCINOMAS
    EBERHART, CE
    COFFEY, RJ
    RADHIKA, A
    GIARDIELLO, FM
    FERRENBACH, S
    DUBOIS, RN
    [J]. GASTROENTEROLOGY, 1994, 107 (04) : 1183 - 1188